Tes Darah Penanda Tumor Dokter Terbaik di Israel - TOP-13 dokter

Dr. Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children’s Hospital (Sourasky). She specializes in bone marrow and umbilical blood transplantation and has conducted over 300 transplantations and published 50 papers and 40 reports. She is a member of American Association for Hematology and Israeli Society for Pediatric Hematooncology, and has previously practiced in the City of Hope Hospital (Los-Angeles) and other medical centers in Israel.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

General Surgeon | Surgical Oncologist | Breast & Melanoma Specialist

Forbes Israel’s “Best Doctors” list (2025)

Areas of Expertise

Professor Dov Zippel specializes in surgical oncology, with a particular focus on breast diseases and skin malignancies:

Breast Cancer

Advanced surgical treatment of malignant breast tumors

Breast Tumors (Benign & Malignant)

Modern minimally invasive and organ-preserving surgical approaches

Melanoma

Surgical management of early and advanced-stage melanoma

Skin Cancer

Comprehensive surgical treatment of various skin malignancies

General Surgery

Wide range of surgical procedures with oncological focus

About the Doctor

Professor Dov Zippel is a highly experienced surgical oncologist and general surgeon, specializing in the treatment of breast cancer and melanoma.

He serves as the Head of the Meirav Breast Center at Sheba Medical Center, where he leads advanced, patient-centered care for individuals with breast diseases.

In addition, Professor Zippel is a surgical specialist at the Ella Lemelbaum Institute for Immuno-Oncology, contributing to multidisciplinary cancer treatment strategies that integrate surgery with modern systemic therapies.

His clinical approach focuses on precision surgery, optimal oncological outcomes, and preservation of quality of life, using up-to-date techniques and individualized treatment planning.

Education and Training

MD, School of Medicine, Tel Aviv University, Israel

Residency in General Surgery, Sheba Medical Center (Department of General Surgery C)

Fellowship (Sub-residency) in Surgical Oncology, University of Calgary, Canada

Board Certifications

General Surgery

Surgical Oncology

Positions

Head of the Meirav Breast Center, Sheba Medical Center

Surgical Oncologist, Ella Lemelbaum Institute for Immuno-Oncology

Research & Publications

Professor Zippel is actively involved in clinical research and has contributed to scientific publications, including:

Use of the Intact® breast lesion excision system as a therapeutic option for selected benign breast lesions

Studies on perioperative BRAF inhibitors in patients with locally advanced stage III melanoma

Chief Physician of the Oncology Center, Oncologist

Gynecologist, Specialist in endoscopic and laparoscopic operations

Oncohematologist

Dr. Nir Kleinmann, MD

Director, Endourology & Kidney Stones Unit – Sheba Medical Center

Leading Expert in Minimally Invasive Urology & Urologic Oncology

Dr. Nir Kleinmann is a highly specialized urologist and internationally trained expert in minimally invasive surgery and urologic oncology, with a strong focus on kidney and upper urinary tract diseases.

He currently serves as Director of the Endourology and Kidney Stones Unit at Sheba Medical Center, one of the world’s leading hospitals. Dr. Kleinmann has been recognized among the Best Doctors in Israel for 2025 and 2026 by Forbes and ResultMed, reflecting his clinical excellence and outstanding patient outcomes.

Areas of Expertise

• Urologic Oncology (Key Focus)
  Upper tract urothelial carcinoma (UTUC), kidney cancer, prostate cancer
• Advanced Stone Disease Management
  • Complex kidney and urinary stones
  • Advanced endoscopic and laser-based treatments
• Minimally Invasive & Organ-Preserving Surgery
  • Endoscopic and laparoscopic procedures
  • Precision techniques aimed at faster recovery and reduced complications
• Prostate Health
  Treatment of benign prostate enlargement (BPH)

Innovation & Advanced Treatments

Dr. Kleinmann is a pioneer in kidney-sparing laser surgery, utilizing a unique dual-laser system (neodymium & holmium) to treat complex tumors while preserving the kidney whenever possible.

His approach focuses on:

• Maximizing cancer control while preserving organ function
• Minimizing surgical trauma and recovery time
• Delivering highly personalized, precision-based care

International Training & Expertise

Dr. Kleinmann completed advanced international fellowships at leading institutions:

• Endourology & Minimally Invasive Surgery Fellowship – Thomas Jefferson University
• Kidney Cancer Research Fellowship – McMaster University

Research & Clinical Leadership

Dr. Kleinmann is actively involved in clinical research and innovation, including participation in the OLYMPUS trial, focusing on non-surgical chemoablation treatments for upper tract urothelial carcinoma.

He has authored 60+ scientific publications, contributing to advancements in:

• Urologic oncology
• Endourology and stone disease
• Minimally invasive treatment approaches
•  

Professional Memberships & Certification

• Israeli Board-Certified Urologist
• Fellow, American Endourology Society
• Member of:
  • Israeli Urological Association
  • European Association of Urology (EAU)

Dr. Kleinmann is dedicated to providing advanced, personalized care, combining international expertise, innovative technology, and a minimally invasive approach to achieve the best possible outcomes while preserving quality of life.